Chemotherapy-induced amenorrhea and fertility in women undergoing adjuvant treatment for breast cancer.
about
Exercise Prevention of Cardiovascular Disease in Breast Cancer SurvivorsPremature menopause or early menopause: long-term health consequencesVulvovaginal atrophy.Decrease in breast density in the contralateral normal breast of patients receiving neoadjuvant chemotherapy: MR imaging evaluationAssessing the usefulness and acceptability of a low health literacy online decision aid about reproductive choices for younger women with breast cancer: the aLLIAnCE pilot study protocolIncidence of chemotherapy-induced amenorrhea after adjuvant chemotherapy with taxane and anthracyclines in young patients with breast cancerPreserving female fertility following cancer treatment: current options and future possibilitiesThe utility of cardiac stress testing for detection of cardiovascular disease in breast cancer survivors: a systematic review.Prevention of bone loss after withdrawal of tamoxifen.Efficient differentiation of steroidogenic and germ-like cells from epigenetically-related iPSCs derived from ovarian granulosa cells.Optimal systemic therapy for early breast cancer in women: a clinical practice guidelineAtrophic vaginitis in breast cancer survivors: a difficult survivorship issue.Making hard choices easier: a prospective, multicentre study to assess the efficacy of a fertility-related decision aid in young women with early-stage breast cancer.Cancer and fertility preservation: fertility preservation in breast cancer patients.Rescue of platinum-damaged oocytes from programmed cell death through inactivation of the p53 family signaling networkOncofertility in Canada: the impact of cancer on fertilityBackground parenchymal enhancement in the contralateral normal breast of patients undergoing neoadjuvant chemotherapy measured by DCE-MRI.The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up.Phosphoramide mustard exposure induces DNA adduct formation and the DNA damage repair response in rat ovarian granulosa cells.Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial).Fertility preserving options in patients with gynecologic malignancies.Optimal adjuvant endocrine therapy for early breast cancer.Fertility and reproductive considerations in premenopausal patients with breast cancer.Agoraphobia and Follicle-Stimulating Hormone Levels between Tamoxifen and Goserelin versus Tamoxifen Alone in Premenopausal Hormone Receptor-Positive Breast Cancer: A 12-Month Prospective Randomized Study.Clinical application of magnetic resonance imaging in management of breast cancer patients receiving neoadjuvant chemotherapy.Frequency and risk factors of mitoxantrone-induced amenorrhea in multiple sclerosis: the FEMIMS study.Examination of the ovotoxicity of 5-fluorouracil in mice.
P2860
Q26785410-4FAB46D2-EBBD-49D7-A49F-90C6B802BC6AQ28257628-9729A67A-C178-428E-A1DC-F6E59F54292FQ33566744-DE88DF0F-1D8E-4E06-9DAE-A80CC9D3F62EQ33746620-6DAEBFCB-0E01-4BA1-BF58-5BC15FFD4D5EQ33776131-27CB5209-3EC4-4F92-BBEB-D8F2D2A61CA6Q34082383-50A3BE91-43A6-433D-B810-04E77BEFFFF9Q34847120-A0AC8D32-09B8-47CA-964E-93527F310859Q35043809-680A0138-93BB-437E-B49A-30AC62C3D834Q35117254-DF06603A-9CC0-43D8-8864-00E2E65A7CD7Q35159151-531BD15C-08CB-4CC9-81EF-797B6CB7ABA5Q35239634-B5A1223B-5832-43C7-9CB6-7F97FEBBB746Q35824414-3B6E5577-FC05-4236-8050-B872B6DAFB33Q35832375-F8D58414-52FE-48B9-825D-0696CAA3D8BBQ36678693-BF7012DB-FEE0-4E60-9537-7D500328E81AQ36994777-8DC0F908-889F-4724-8D81-DB4F16EA3D81Q37056902-905CE3F4-40CD-424B-981E-74A63A9BC2D7Q37227664-7F993BFC-D46C-40DA-BC5A-5029D49C6FB4Q37289219-751BAAB2-7FF5-4EDC-89F7-E3EF5EA6E185Q37300326-385AEC40-E679-46FD-9F78-E0148DC4CA15Q37325544-764154C5-57DF-49DE-80D5-B0EDA4A6174BQ37418317-01486257-EB03-4FC5-9C40-6F03282F21D7Q37738877-A7BCB0F5-996D-4944-9E75-743F2B8AF791Q37776142-8352EC3E-7C4D-4C6A-89AF-4A68D43633A2Q41449756-0BF77AE0-D512-4B08-AE1A-997006AD89A3Q44491240-CAC01324-5B50-437C-9DE0-4408D03FBA9FQ46431006-8DF25A06-8959-48C7-99E9-D8FE0B09E823Q52626212-E82C9A4F-D4C9-4478-9424-C0E3639953E8
P2860
Chemotherapy-induced amenorrhea and fertility in women undergoing adjuvant treatment for breast cancer.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Chemotherapy-induced amenorrhe ...... t treatment for breast cancer.
@ast
Chemotherapy-induced amenorrhe ...... t treatment for breast cancer.
@en
type
label
Chemotherapy-induced amenorrhe ...... t treatment for breast cancer.
@ast
Chemotherapy-induced amenorrhe ...... t treatment for breast cancer.
@en
prefLabel
Chemotherapy-induced amenorrhe ...... t treatment for breast cancer.
@ast
Chemotherapy-induced amenorrhe ...... t treatment for breast cancer.
@en
P2860
P1433
P1476
Chemotherapy-induced amenorrhe ...... t treatment for breast cancer.
@en
P2093
Pamela N Munster
Susan E Minton
P2860
P304
P356
10.1177/107327480200900603
P577
2002-11-01T00:00:00Z